Hospital or health organisation · founded 1981
Moffitt Cancer Center
Tampa, United States · moffitt.org
- Citations, last 5 years
- 134.7k
- Works, last 5 years
- 13.7k
- h-index
- 815
- Scientists listed
- 950
- Grants since 2016
- 1 073
Grants received
2017–2021 · research · R21
Sequence variation in mtDNA and extreme survival in glioblastoma
Kathleen M. Egan · Moffitt Cancer Center · funded by National Institutes of Health
2017–2024 · research · R01
Investigation of Oral HPV Infection Natural History and Biomarkers of Persistent Infection: The HIM Study
Anna R. Giuliano · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Investigation of Oral HPV Infection Natural History and Biomarkers of Persistent Infection: The HIM Study
Anna R. Giuliano · Moffitt Cancer Center · funded by National Institutes of Health
2017–2023 · research · R01
Cell free nucleic acid-based biomarkers in advanced prostate cancer
Manish Kohli · Moffitt Cancer Center · funded by National Institutes of Health
2017–2020 · research · R00
Deconstructing the molecular mechanisms of Notch receptor-ligand selectivity
Vincent Christopher Luca · Moffitt Cancer Center · funded by National Institutes of Health
2017–2019 · research · R21
Applying Chemical Biology to Target Deubiquitinating Enzymes in Lung Cancer
Eric B. Haura · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Investigation of Oral HPV Infection Natural History and Biomarkers of Persistent Infection: The HIM Study
Anna R. Giuliano · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Targeting a Novel Epigenetic Signaling Nexus ACK1-pY88H4-AR/AR-V7 in Drug Resistant Metastatic Prostate Cancer
Nupam P Mahajan · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R00
A clone's genomic stability as biomarker of its DNA-damage resilience
Noemi Andor · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R00
A clone's genomic stability as biomarker of its DNA-damage resilience
Noemi Andor · Moffitt Cancer Center · funded by National Institutes of Health
2017–2025 · research · R01
Cell free nucleic acid-based biomarkers in advanced prostate cancer
Manish Kohli · Moffitt Cancer Center · funded by National Institutes of Health
2017–2018 · research · R01
Effects of Common Polymorphisms in Immune Sensors in Tumor Immunosurveillance
Jose R Conejo-Garcia · Moffitt Cancer Center · funded by National Institutes of Health
2017–2023 · research · R01
Targeting bidirectional signaling in lung stroma and cancer cells
Eric B. Haura · Moffitt Cancer Center · funded by National Institutes of Health
2017–2024 · research · R01
Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade
Amer Aziz Beg · Moffitt Cancer Center · funded by National Institutes of Health
2017–2019 · research · R21
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
Peter Alexander Forsyth · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R50
Developing Chemical Probes for Oncogenic Signaling Pathways
Harshani R Lawrence · Moffitt Cancer Center · funded by National Institutes of Health
2017–2019 · research · R01
Targeting a Novel Epigenetic Signaling Nexus ACK1-pY88H4-AR/AR-V7 in Drug Resistant Metastatic Prostate Cancer
Nupam P Mahajan · Moffitt Cancer Center · funded by National Institutes of Health
2017–2021 · program · P20
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
William Douglas Cress · Moffitt Cancer Center · funded by National Institutes of Health
2017–2018 · research · R01
Effects of Common Polymorphisms in Immune Sensors in Tumor Immunosurveillance
Jose R Conejo-Garcia · Moffitt Cancer Center · funded by National Institutes of Health
2017–2028 · research · R50
Developing chemical probes for oncogenic signaling pathways
Harshani R Lawrence · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Investigation of Oral HPV Infection Natural History and Biomarkers of Persistent Infection: The HIM Study
Anna R. Giuliano · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade
Amer Aziz Beg · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade
Amer Aziz Beg · Moffitt Cancer Center · funded by National Institutes of Health
2017–2021 · research · R00
The Role of Inflammation in the Racial Disparities in Ovarian Cancer Survival
Lauren Cole Peres · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R00
The Role of Inflammation in the Racial Disparities in Ovarian Cancer Survival
Lauren Cole Peres · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R50
Developing Chemical Probes for Oncogenic Signaling Pathways
Harshani R Lawrence · Moffitt Cancer Center · funded by National Institutes of Health
2017–2021 · program · P20
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
William Douglas Cress · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R50
Developing Chemical Probes for Oncogenic Signaling Pathways
Harshani R Lawrence · Moffitt Cancer Center · funded by National Institutes of Health
2017–2020 · research · R00
Deconstructing the molecular mechanisms of Notch receptor-ligand selectivity
Vincent Christopher Luca · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R50
Developing Chemical Probes for Oncogenic Signaling Pathways
Harshani R Lawrence · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Targeting bidirectional signaling in lung stroma and cancer cells
Eric B. Haura · Moffitt Cancer Center · funded by National Institutes of Health
2017–2019 · research · R21
Applying Chemical Biology to Target Deubiquitinating Enzymes in Lung Cancer
Eric B. Haura · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · program · P20
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
William Douglas Cress · Moffitt Cancer Center · funded by National Institutes of Health
2017–2028 · research · R50
Developing chemical probes for oncogenic signaling pathways
Harshani R Lawrence · Moffitt Cancer Center · funded by National Institutes of Health
2017–2019 · research · R21
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
Peter Alexander Forsyth · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Targeting bidirectional signaling in lung stroma and cancer cells
Eric B. Haura · Moffitt Cancer Center · funded by National Institutes of Health
2017–2021 · program · P20
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
William Douglas Cress · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade
Amer Aziz Beg · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R50
Developing Chemical Probes for Oncogenic Signaling Pathways
Harshani R Lawrence · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Targeting bidirectional signaling in lung stroma and cancer cells
Eric B. Haura · Moffitt Cancer Center · funded by National Institutes of Health